TIANYIN PHARMACEUTICAL CO IN COM - 88630M104
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2014
· Q4 2013
Value (USD)
Total reported value ($000)
$3.029M
QoQ value delta ($000)
-$1.541M
(-33.72%)
Implied price effect (QoQ)
+24.16%
Shares
Total shares
3,085,379
QoQ shares delta
-2,694,167
(-46.62%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Top holders (Q1 2014)
Top 25 only
Full list
Early Q3 2021 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 2,244 | 2,284,900 | 1.29% |
| RENAISSANCE TECHNOLOGIES LLC | 609 | 620,100 | 0.0% |
| KCG Holdings, Inc. | 39 | 40,039 | 0.0% |
| CITADEL ADVISORS LLC | 38 | 39,092 | 0.0% |
| Rotella Capital Management, Inc. | 30 | 30,305 | 0.04% |
| Spark Investment Management LLC | 25 | 25,900 | 0.0% |
| Regent Investment Management LLC | 24 | 24,600 | 0.01% |
| CREDIT SUISSE AG/ | 15 | 15,343 | 0.0% |
| Baltimore-Washington Financial Advisors, Inc. | 5 | 5,100 | 0.0% |